US7444132044
US7444132044
P3 Health Partners Inc.
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.7x as much as the broader market.
Beta (Market Relation)
1.69x
Above averageVolatility (5Y p.a.)
130.8% p.a.
5-Year HorizonMax Drawdown (5Y)
-99.7%
5-Year HorizonSharpe Ratio
-0.47
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -40.7% |
| 3 Years | 149.2% | -98.3% | -0.42 | -60.8% |
| 5 Years | 130.8% | -99.7% | -0.47 | -59.6% |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.69 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (149.2%) is noticeably higher than the 5Y average (130.8%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (130.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.7% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
-
Audit Risk
-
Board Risk
-
Short Ratio
1.19